Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text question first answered answering member label
creator	label
publisher
tabling member	label

Search

1125231

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:53:57
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 17:55:06 16/05/2019 12:16:02
	hansard heading	HIV Infection: Drugs
	house id	1
	identifier	251999
	legislature	25259
	parliament number	57
	question first answered	16/05/2019 11:44:51
	question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the availability of HIV Pre-Exposure Prophylaxis (PrEP) in (a) Bristol and (b) England.
	session	2017/19
	session number	1
	tabling member constituency	Bristol West
	tabling member printed	Thangam Debbonaire
	title	House of Commons Tabled Parliamentary Question 2017/19 251999
	type	WrittenParliamentaryQuestion
	uin	251999
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>In February 2019, additional HIV Pre-Exposure Prophylaxis (PrEP) Impact trial allocation places were released to those sexual health clinics in Bristol, the Bristol Royal Infirmary and the Concord Clinic participating in the PrEP trial.</p><p>These additional places in Bristol are part of the overall expansion of 13,000 additional PrEP trial places across England, increasing the total number of places to 26,000 for participating clinics. The trial website can be viewed at the following link:</p><p><a href="https://www.prepimpacttrial.org.uk/join-the-trial" target="_blank">https://www.prepimpacttrial.org.uk/join-the-trial</a></p> question first answered 16/05/2019 11:44:51 answering member 4455 label Biography information for Seema Kennedy
	creator	4433 label Biography information for Thangam Debbonaire
	publisher	25259
	tabling member	4433 label Biography information for Thangam Debbonaire

1125248

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:54:46
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/05/2019 14:55:06 17/05/2019 13:43:02
	hansard heading	Ovarian Cancer
	house id	1
	identifier	252008
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 13:11:39
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) improve early diagnosis of ovarian cancer and (b) reduce the level of variation in diagnosis times between clinical commissioning groups.
	session	2017/19
	session number	1
	tabling member constituency	North East Derbyshire
	tabling member printed	Lee Rowley
	title	House of Commons Tabled Parliamentary Question 2017/19 252008
	type	WrittenParliamentaryQuestion
	uin	252008
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The NHS Cancer Programme is committed to improving early diagnosis as outlined in the Long Term Plan ambition to diagnose three-quarters of all cancers at stages 1 and 2 by 2028. This includes all stageable cancers.</p><p>To achieve this ambition, the NHS Cancer Programme is working on a number of programmes to improve early diagnosis rates for all cancers. The Rapid Diagnostic Centres (RDCs) are a new flagship policy in the Long Term Plan that offer patients a range of tests in the same day with rapid access to results. These RDCs starting to be rolled out in 2019/20 and will support the overall early diagnosis ambition. The RDCs will upgrade and bring together the latest diagnostic equipment and expertise, building on 10 models piloted with Cancer Research UK, which have focused on diagnosing cancers where patients often present with non-specific symptoms, often the case with ovarian cancer, and may go to their general practitioner many times before being sent for tests, such as blood and stomach cancers.</p><p> </p><p>A new cancer diagnosis standard, designed to ensure that patients find out within 28 days if they have cancer, will be introduced in 2020. All hospitals in England are now collecting data on how long it takes patients to reach cancer diagnosis, and they are working to improve performance over the next year and reduce unwarranted variation, for example geographical variation.</p><p> </p><p><strong> </strong></p> question first answered 17/05/2019 13:11:39 answering member 4455 label Biography information for Seema Kennedy
	creator	4652 label Biography information for Lee Rowley
	publisher	25259
	tabling member	4652 label Biography information for Lee Rowley

1125254

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:55:02
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:05:16 16/05/2019 13:59:02
	hansard heading	Social Services: Fees and Charges
	house id	1
	identifier	251936
	legislature	25259
	parliament number	57
	question first answered	16/05/2019 13:27:28
	question text	To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number of years a person would need to spend in a residential care home before benefitting from an (a) £72,000 cap and (b) £100,000 cap on the cost of care; if he will make it his policy to introduce free personal care in England; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Brighton, Pavilion
	tabling member printed	Caroline Lucas
	title	House of Commons Tabled Parliamentary Question 2017/19 251936
	type	WrittenParliamentaryQuestion
	uin	251936
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The social care Green Paper will bring forward ideas for including an element of risk pooling in the system, which will help to protect people from the highest costs. To allow for fuller engagement and development of the approach, with reforms to the care system and the way it is paid for considered in the round, we will not be taking forward the previous Government’s plans to implement a cap on care costs in 2020. Further details on the Government’s plans will be set out after we have consulted on the different options.</p> question first answered 16/05/2019 13:27:28 answering member 4008 label Biography information for Dame Caroline Dinenage
	creator	3930 label Biography information for Caroline Lucas
	publisher	25259
	tabling member	3930 label Biography information for Caroline Lucas

1125272

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:56:05
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:06:18 17/05/2019 13:56:01
	hansard heading	Strokes: Death
	house id	1
	identifier	251938
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 13:24:45
	question text	To ask the Secretary of State for Health and Social Care, how many deaths caused by stroke there were in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to stroke in that period with the (a) expected average and (b) average over the last five years.
	session	2017/19
	session number	1
	tabling member constituency	Hammersmith
	tabling member printed	Andy Slaughter
	title	House of Commons Tabled Parliamentary Question 2017/19 251938
	type	WrittenParliamentaryQuestion
	uin	251938
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>According to the Daily Air Quality Index there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April and between 15 to 25 April 2019. The figures for deaths caused by stroke in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> question first answered 17/05/2019 13:24:45 answering member 4455 label Biography information for Seema Kennedy
	creator	1516 label Biography information for Andy Slaughter
	publisher	25259
	tabling member	1516 label Biography information for Andy Slaughter

1125273

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:56:09
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:06:20 17/05/2019 13:54:02
	hansard heading	Heart Diseases: Death
	house id	1
	identifier	251939
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 13:22:33
	question text	To ask the Secretary of State for Health and Social Care, how many deaths were caused by coronary heart disease in affected areas in England during the pollution episode in April 2019; and what comparative assessment he has made of the number of deaths attributed to heart disease in that period with the (a) expected average and (b) average over the last five years.
	session	2017/19
	session number	1
	tabling member constituency	Hammersmith
	tabling member printed	Andy Slaughter
	title	House of Commons Tabled Parliamentary Question 2017/19 251939
	type	WrittenParliamentaryQuestion
	uin	251939
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>According to the Daily Air Quality Index, there were ‘moderate’ to ‘very high’ levels of air pollution in some areas of the United Kingdom between 7 and 8 April 2019 and between 15 and 25 April 2019. The figures for deaths caused by coronary heart disease in this period are not available in the requested format and a comparative assessment has not been made.</p><p>In January 2019, the Government launched the Clean Air Strategy, which sets out plans for dealing with all sources of air pollution to save lives, protect nature and boost the economy.</p> question first answered 17/05/2019 13:22:33 answering member 4455 label Biography information for Seema Kennedy
	creator	1516 label Biography information for Andy Slaughter
	publisher	25259
	tabling member	1516 label Biography information for Andy Slaughter

1125285

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:56:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:06:46 17/05/2019 13:47:01
	hansard heading	Health Services: Rural Areas
	house id	1
	identifier	252028
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 13:15:13
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department taking to enable the use of digital technology to increase access to healthcare for people in rural communities.
	session	2017/19
	session number	1
	tabling member constituency	North Cornwall
	tabling member printed	Scott Mann
	title	House of Commons Tabled Parliamentary Question 2017/19 252028
	type	WrittenParliamentaryQuestion
	uin	252028
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Digital technology is improving access to healthcare for rural communities:</p><p>- In April 2018, NHS Digital published a digital inclusion guide for health and social care aimed at local health and care organisations to help them to take practical steps to support digital inclusion in their communities, including those in rural areas who are more likely to be digitally excluded;</p><p> </p><p>- We are working closely with the Department for Digital, Culture, Media and Sport to ensure that health and care needs are taken into account in national digital infrastructure policy, are running two test beds under Department for Digital, Culture, Media and Sport’s 5G programme focused on improving access, and the 5G programme itself will address rural connectivity; and</p><p> </p><p>- The NHS App is now connected in over 52% of general practitioner (GP) practices. It provides a universal offer regardless of postcode. It gives patients a single safe and secure means to interact with their GP, including access to their GP record, make GP appointments, order repeat prescriptions, access 111 online for urgent medical questions. The improved NHS website has over 40 million visits a month.</p> question first answered 17/05/2019 13:15:13 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	creator	4496 label Biography information for Scott Mann
	publisher	25259
	tabling member	4496 label Biography information for Scott Mann

1125320

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:58:17
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:08:19 17/05/2019 13:06:01
	hansard heading	Asthma: Prescriptions
	house id	1
	identifier	251955
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 12:34:53
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of asthma prescription charges on lifelong asthma sufferers.
	session	2017/19
	session number	1
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	title	House of Commons Tabled Parliamentary Question 2017/19 251955
	type	WrittenParliamentaryQuestion
	uin	251955
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department has made no such assessment.</p> question first answered 17/05/2019 12:34:53 answering member 4455 label Biography information for Seema Kennedy
	creator	1447 label Biography information for Andrew Rosindell
	publisher	25259
	tabling member	1447 label Biography information for Andrew Rosindell

1125327

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:58:36
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/05/2019 15:15:08 16/05/2019 12:31:02
	hansard heading	Healthy Start Scheme
	house id	1
	identifier	251898
	legislature	25259
	parliament number	57
	question first answered	16/05/2019 11:59:47
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to encourage (a) Morrisons, (b) Tesco, (c) Asda, (d) Sainsburys and (d) other supermarket chains to promote the acceptance of Healthy Start Vouchers to their customers; and if he will make a statement.
	session	2017/19
	session number	1
	tabling member constituency	Harrow West
	tabling member printed	Gareth Thomas
	title	House of Commons Tabled Parliamentary Question 2017/19 251898
	type	WrittenParliamentaryQuestion
	uin	251898
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Information about the Healthy Start scheme is available to the public and retailers on the Healthy Start website. Retailers are encouraged to use promotional materials available on the Healthy Start website to promote their acceptance of the vouchers.</p> question first answered 16/05/2019 11:59:47 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	creator	177 label Biography information for Gareth Thomas
	publisher	25259
	tabling member	177 label Biography information for Gareth Thomas

1125336

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 17:59:00
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	09/05/2019 15:15:10 17/05/2019 13:45:03
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	identifier	252045
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 13:13:17
	question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to review which long-term health conditions should be exempt from NHS prescription charges.
	session	2017/19
	session number	1
	tabling member constituency	Hornsey and Wood Green
	tabling member printed	Catherine West
	title	House of Commons Tabled Parliamentary Question 2017/19 252045
	type	WrittenParliamentaryQuestion
	uin	252045
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The Department has no current plans to review or amend the list of medical conditions that provide exemption from prescription charges. Extensive arrangements are already in place to help people afford National Health Service prescriptions. These include a broad range of NHS prescription charge exemptions.</p><p>To support those with greatest need who do not qualify for an exemption, prescription prepayment certificates are available. A holder of a 12-month certificate can get all the prescriptions they need for just £2 per week.</p> question first answered 17/05/2019 13:13:17 answering member 4455 label Biography information for Seema Kennedy
	creator	4523 label Biography information for Catherine West
	publisher	25259
	tabling member	4523 label Biography information for Catherine West

1125364

	human indexable
	published
	registered interest
	answer date	13/05/2019
	date	08/05/2019
	date tabled	08/05/2019
	ddp created	08/05/2019 18:00:19
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	08/05/2019 18:10:08 17/05/2019 13:07:01
	hansard heading	Ocrelizumab
	house id	1
	identifier	252055
	legislature	25259
	parliament number	57
	question first answered	17/05/2019 12:35:52
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on the (a) negotiations for NHS access to and (b) appraisal of Ocrelizumab as a treatment for primary progressive MS.
	session	2017/19
	session number	1
	tabling member constituency	South Cambridgeshire
	tabling member printed	Heidi Allen
	title	House of Commons Tabled Parliamentary Question 2017/19 252055
	type	WrittenParliamentaryQuestion
	uin	252055
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based guidance for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources.</p><p>NICE is currently developing technology appraisal guidance on the use of ocrelizumab for treating primary progressive multiple sclerosis, with final guidance expected in June 2019. NHS England and Roche have now reached a commercial agreement and on 9 May NICE published final draft guidance which recommended ocrelizumab within its marketing authorisation, as an option for treating early primary progressive multiple sclerosis with imaging features characteristic of inflammatory activity in adults. Ocrelizumab will now be routinely available for eligible adults.</p><p> </p> question first answered 17/05/2019 12:35:52 answering member 4455 label Biography information for Seema Kennedy
	creator	4516 label Biography information for Heidi Allen
	publisher	25259
	tabling member	4516 label Biography information for Heidi Allen